v3.26.1
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES    
Net Loss $ (4,355,741) $ (3,612,231)
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities:    
Depreciation 33,651 15,930
Amortization 23,025 20,545
Amortization of Capitalized Share-Based Payments 96,005 88,235
Share-Based Compensation under Equity Incentive Plan 126,502 177,148
Change in Fair Value of Derivative Liabilities 10,232 135,342
Change in Inventory Reserve (251,677)
Changes in Operating Assets and Liabilities:    
Accounts Receivable (57,396) 191,714
Prepaid and Other Assets (381,580) 263,911
Inventory 30,656 (356,657)
Accounts Payable and Accrued Liabilities (251,082) 9,739
Accrued Interest, net 4,125 18,830
Net Cash Used in Operating Activities (4,973,280) (3,047,494)
CASH FLOWS FROM INVESTING ACTIVITIES    
Capitalization of Patents (33,048) (7,165)
Purchases of Fixed Assets (30,000) (50,001)
Acquisition of Intangibles (64,376)
Maturities of Short-Term Investments 1,235,000 1,708,000
Net Cash Provided by Investing Activities 1,107,576 1,650,834
CASH FLOWS FROM FINANCING ACTIVITIES    
Net Proceeds from ATM Offering 3,369,752
Net Proceeds from January 2025 Offering 804,346
Net Proceeds from February 2025 Offering 908,627
Shares Withheld for Net Share Settlement of Performance Bonuses (18,000)
Proceeds from Exercise of Pre-Funded Warrants 1,926
Net Cash Provided by Financing Activities 3,369,752 1,696,899
Effect of Exchange Rate Changes on Cash 8,493 7,338
Change in Cash and Cash Equivalents (487,459) 307,577
Cash and Cash Equivalents—Beginning of Period 1,510,065 1,659,353
Cash and Cash Equivalents—End of Period 1,022,606 1,966,930
NONCASH INVESTING/FINANCING ACTIVITIES    
Purchases of Fixed Assets included in Accounts Payable 10,000
Capitalized Patent Costs included in Accounts Payable 1,419
Capitalized Software Costs included in Accounts Payable 8,503
Gross Shares Issued for Annual Performance Bonuses $ 121,544